9.0.0.0 Ref­er­ences

1. Cen­ters for Dis­ease Con­trol and Pre­ven­tion. Na­tion­al Di­a­betes Statis­tics Re­port [In­ter­net], 2017. Avail­able from https://www.cdc.gov/di­a­betes/data/statistics/statistics-re­port.html. Ac­cessed 20 Septem­ber 2018
2. Kirk­man MS, Briscoe VJ, Clark N, et al. Di­a­betes in older adults. Di­a­betes Care 2012;35: 2650–2664
3. Young-‍Hyman D, de Groot M, Hill-‍Brig­gs F, Gon­za­lez JS, Hood K, Pey­rot M. Psychoso­cial care for peo­ple with di­a­betes: a po­si­tion state­ment of the Amer­i­can Di­a­betes As­so­ci­a­tion. Di­a­betes Care 2016;39:2126–2140
4. In­sti­tute of Medicine of the Na­tion­al Academies. Cog­ni­tive Aging: Progress in Un­der­stand­ing and Op­por­tu­ni­ties for Ac­tion [In­ter­net], 2015. Avail­able from http:/‍/‍nationalacademies.org/hmd/Re­ports/2015/Cog­ni­tive-Aging.aspx. Ac­cessed 20 Septem­ber 2018
5. Kim­bro LB, Man­gione CM, Steers WN, et al. De­pres­sion and all-‍cause mor­tal­i­ty in per­sons with di­a­betes mel­li­tus: are older adults at high­er risk? Re­sults from the Trans­lat­ing Re­search Into Ac­tion for Di­a­betes Study. J Am Geri­atr Soc 2014; 62:1017–1022
6. Cukier­man T, Ger­stein HC, Williamson JD. Cog­ni­tive de­cline and de­men­tia in di­a­betes– sys­tematic overview of prospec­tive ob­ser­va­tion­al stud­ies. Di­a­betolo­gia 2005;48:2460–2469
7. Roberts RO, Knop­man DS, Przy­bel­s­ki SA, et al. As­so­ci­a­tion of type 2 di­a­betes with brain at­ro­phy and cog­ni­tive im­pair­ment. Neu­rol­o­gy 2014;82: 1132–1141
8. Xu WL, von Strauss E, Qiu CX, Win­blad B, Fratiglioni L. Uncon­trolled di­a­betes in­creases the risk of Alzheimer’s dis­ease: a pop­u­la­tion-‍based co­hort study. Di­a­betolo­gia 2009;52: 1031–1039
9. Ghezzi L, Scarpi­ni E, Gal­im­ber­ti D. Dis­ease-modifying drugs in Alzheimer’s dis­ease. Drug Des Devel Ther 2013;7:1471–1478
10. Craft S, Baker LD, Mon­tine TJ, et al. In­tranasal in­sulin ther­a­py for Alzheimer dis­ease and amnes­tic mild cog­ni­tive im­pair­ment: a pilot clin­i­cal trial. Arch Neu­rol 2012;69:29–38
11. Frei­herr J, Hallschmid M, Frey WH 2nd, et al. In­tranasal in­sulin as a treat­ment for Alzheimer’s dis­ease: a re­view of basic re­search and clin­i­cal ev­i­dence. CNS Drugs 2013;27:505–514
12. Ala­giakr­ish­nan K, Sankar­alingam S, Ghosh M, Mereu L, Se­nior P. An­tidi­a­bet­ic drugs and their po­ten­tial role in treat­ing mild cog­ni­tive im­pair­ment and Alzheimer’s dis­ease. Dis­cov Med 2013; 16:277–286
13. Yaffe K, Falvey C, Hamil­ton N, et al. Di­a­betes, glu­cose con­trol, and 9-year cog­ni­tive de­cline among older adults with­out de­men­tia. Arch Neu­rol 2012;69:1170–1175
14. Launer LJ, Miller ME, Williamson JD, et al.; AC­CORD MIND in­ves­ti­ga­tors. Ef­fects of in­ten­sive glu­cose low­er­ing on brain struc­ture and func­tion in peo­ple with type 2 di­a­betes (AC­CORD MIND): a ran­dom­ized open-‍label sub­study. Lancet Neu­rol 2011;10:969–977
15. Mur­ray AM, Hsu F-C, Williamson JD, et al.; Ac­tion to Con­trol Cardiovas­cu­lar Risk in Di­a­betes Fol­low-‍On Mem­o­ry in Di­a­betes (AC­CORDION MIND) In­ves­ti­ga­tors. AC­CORDION MIND: re­sults of the ob­ser­va­tion­al ex­ten­sion of the AC­CORD MIND ran­domised trial. Di­a­betolo­gia 2017;60: 69–80
16. Cum­mings JL, Frank JC, Cher­ry D, et al. Guide­lines for man­ag­ing Alzheimer’s dis­ease: part I. As­sess­ment. Am Fam Physi­cian 2002; 65:2263–2272
17. Nasred­dine ZS, Phillips NA, Be´diri­an V, et al. The Mon­tre­al Cog­ni­tive As­sess­ment, MoCA: a brief screen­ing tool for mild cog­ni­tive im­pair­ment. J Am Geri­atr Soc 2005;53:695–699
18. Moreno G, Man­gione CM, Kim­bro L, Vais­berg E; Amer­i­can Geri­atrics So­ci­ety Ex­pert Panel on Care of Older Adults with Di­a­betes Mel­li­tus. Guide­lines ab­stract­ed from the Amer­i­can Geri­atrics So­ci­ety guide­lines for im­prov­ing the care of older adults with di­a­betes mel­li­tus: 2013 up­date. J Am Geri­atr Soc 2013;61:2020– 2026
19. Amer­i­can Psy­cho­log­i­cal As­so­ci­a­tion. Guide­lines for the Eval­u­a­tion of De­men­tia and Age- Re­lat­ed Cog­ni­tive Change [In­ter­net], 2011. Avail­able from http://www.apa.org/prac­tice/guide­lines/de­men­tia.aspx. Ac­cessed 20 Septem­ber 2018
20. Feinkohl I, Aung PP, Keller M, et al.; Ed­in­burgh Type 2 Di­a­betes Study (ET2DS) In­ves­ti­ga­tors. Se­vere hy­po­glycemia and cog­ni­tive de­cline in older peo­ple with type 2 di­a­betes: the Ed­in­burgh Type 2 Di­a­betes Study. Di­a­betes Care 2014;37:507–515
21. Ja­cob­son AM, Musen G, Ryan CM, et al.; Di­a­betes Con­trol and Com­pli­ca­tions Trial/‍ Epi­demi­ol­o­gy of Di­a­betes In­ter­ven­tions and Com­pli­ca­tions Study Re­search Group. Long-term ef­fect of di­a­betes and its treat­ment on cog­ni­tive func­tion. N Engl J Med 2007;356: 1842–1852
22. Selvin E, Core­sh J, Bran­cati FL. The bur­den and treat­ment of di­a­betes in el­der­ly in­di­vid­u­als in the U.S. Di­a­betes Care 2006;29:2415–2419
23. Bandeen-‍Roche K, Se­pla­ki CL, Huang J, et al. Frailty in older adults: a na­tion­al­ly rep­re­sen­ta­tive profile in the Unit­ed States. J Geron­tol A Biol Sci Med Sci 2015;70:1427–1434
24. Kalyani RR, Tian J, Xue Q-L, et al. Hy­per­glycemia and in­ci­dence of frailty and lower ex­trem­i­ty mo­bil­i­ty lim­i­ta­tions in older women. J Am Geri­atr Soc 2012;60:1701–1707
25. Blaum C, Cigolle CT, Boyd C, et al. Clin­i­cal com­plexity in mid­dle-‍aged and older adults with di­a­betes: the Health and Re­tire­ment Study. Med Care 2010;48:327–334
26. NGSP. Fac­tors that In­ter­fere with HbA1c Test Re­sults [In­ter­net], 2018. Avail­able from http://www.ngsp.org/fac­tors.asp. Ac­cessed 20 Septem­ber 2018
27. Sin­clair A, Dun­ning T, Co­lag­iuri S. IDF Glob­al Guide­line For Man­ag­ing Older Peo­ple With Type 2 Di­a­betes. In­ter­na­tion­al Di­a­betes Fed­er­a­tion, Brus­sels, Bel­gium, 2013
28. An­ge­lo M, Ruchal­s­ki C, Sproge BJ. An ap­proach to di­a­betes mel­li­tus in hos­pice and pal­lia­tive medicine. J Pal­li­at Med 2011;14: 83–87
29. Beck­ett NS, Pe­ters R, Fletch­er AE, et al.; HYVET Study Group. Treat­ment of hy­per­ten­sion in pa­tients 80 years of age or older. N Engl J Med 2008;358:1887–1898
30. de Boer IH, Ban­ga­lore S, Bene­tos A, et al. Di­a­betes and hy­per­ten­sion: a po­si­tion state­ment by the Amer­i­can Di­a­betes As­so­ci­a­tion. Di­a­betes Care 2017;40:1273–1284
31. Sin­clair AJ, Ab­del­hafiz A, Dun­ning T, et al. An in­ter­na­tion­al po­si­tion state­ment on the man­age­ment of frailty in di­a­betes mel­li­tus: sum­ma­ry of rec­om­men­da­tions 2017. J Frailty Aging 2018; 7:10–20
32. Cas­tro-‍Rodr´ıguez M, Car­nicero JA, Gar­cia-‍ Gar­cia FJ, et al. Frailty as a major fac­tor in the in­creased risk of death and dis­abil­i­ty in older peo­ple with di­a­betes. J Am Med Dir Assoc 2016; 17:949–955
33. Va­len­cia WM, Flo­rez H. Phar­ma­co­log­i­cal treat­ment of di­a­betes in older peo­ple. Di­a­betes Obes Metab 2014;16:1192–1203
34. An­dreassen LM, Sand­berg S, Kris­tensen GBB, Sølvik UØ, Kjome RLS. Nurs­ing home pa­tients with di­a­betes: preva­lence, drug treat­ment and glycemic con­trol. Di­a­betes Res Clin Pract 2014; 105:102–109
35. Lip­s­ka KJ, Ross JS, Miao Y, Shah ND, Lee SJ, Stein­man MA. Po­ten­tial overtreat­ment of di­a­betes mel­li­tus in older adults with tight glycemic con­trol. JAMA In­tern Med 2015;175:356–362
36. Thor­pe CT, Gel­lad WF, Good CB, et al. Tight glycemic con­trol and use of hy­po­glyce­mic med­i­ca­tions in older vet­er­ans with type 2 di­a­betes and co­mor­bid de­men­tia. Di­a­betes Care 2015; 38:588–595
37. McAl­is­ter FA, Young­son E, Eu­rich DT. Treat­ment dein­ten­sification is uncom­mon in adults with type 2 di­a­betes mel­li­tus: a ret­ro­spec­tive co­hort study. Circ Car­dio­vasc Qual Out­comes 2017;10:e003514
38. Arnold SV, Lip­s­ka KJ, Wang J, Seman L, Mehta SN, Kosi­borod M. Use of in­ten­sive glycemic man­age­ment in older adults with di­a­betes mel­li­tus. J Am Geri­atr Soc 2018;66:1190–1194
39. Mun­shi MN, Slyne C, Segal AR, Saul N, Lyons C, Weinger K. Sim­plification of in­sulin reg­i­men in older adults and risk of hy­po­glycemia. JAMA In­tern Med 2016;176:1023–1025
40. Suss­man JB, Kerr EA, Saini SD, et al. Rates of dein­ten­sification of blood pres­sure and glycemic med­i­ca­tion treat­ment based on lev­els of con­trol and life ex­pectan­cy in older pa­tients with di­a­betes mel­li­tus. JAMA In­tern Med 2015;175: 1942–1949
41. Ab­del­hafiz AH, Sin­clair AJ. Dein­ten­sification of hy­po­gly­caemic med­i­ca­tions-‍use of a sys­tematic re­view ap­proach to high­light safe­ty con­cerns in older peo­ple with type 2 di­a­betes. J Di­a­betes Com­pli­ca­tions 2018;32:444–450
42. In­zuc­chi SE, Lip­s­ka KJ, Mayo H, Bai­ley CJ, McGuire DK. Met­formin in pa­tients with type 2 di­a­betes and kid­ney dis­ease: a sys­tematic re­view. JAMA 2014;312:2668–2675
43. Amer­i­can Geri­atrics So­ci­ety 2015 Beers Cri­te­ria Up­date Ex­pert Panel. Amer­i­can Geri­atrics So­ci­ety 2015 up­dated Beers cri­te­ria for po­ten­tially inap­pro­pri­ate med­i­ca­tion use in older adults. J Am Geri­atr Soc 2015;63:2227–2246
44. Davies MJ, D’Alessio DA, Frad­kin J. Man­age­ment of hy­per­glycemia in type 2 di­a­betes, 2018. A con­sen­sus re­port by the Amer­i­can Di­a­betes As­so­ci­a­tion (ADA) and the Eu­ro­pean As­so­ci­a­tion for the Study of Di­a­betes (EASD). Di­a­betes Care 2018;41:2669–2701
45. Laiteer­apong N, Karter AJ, Liu JY, et al. Cor­re­lates of qual­i­ty of life in older adults with di­a­betes: the Di­a­betes & Aging Study. Di­a­betes Care 2011;34:1749–1753
46. Mun­shi MN, Flo­rez H, Huang ES, et al. Man­age­ment of di­a­betes in long-‍term care and skilled nurs­ing fa­cil­i­ties: a po­si­tion state­ment of the Amer­i­can Di­a­betes As­so­ci­a­tion. Di­a­betes Care 2016;39:308–318
47. Sin­clair A, Mor­ley JE, Ro­driguez-‍Man~as L, et al. Di­a­betes mel­li­tus in older peo­ple: po­si­tion state­ment on be­half of the In­ter­na­tion­al As­so­ci­a­tion of Geron­tology and Geri­atrics (IAGG), the Eu­ro­pean Di­a­betes Work­ing Party for Older Peo­ple (ED­W­POP), and the In­ter­na­tion­al Task Force of Ex­perts in Di­a­betes. J Am Med Dir Assoc 2012;13:497–502
48. Dorner B, Friedrich EK, Posthauer ME. Prac­tice paper of the Amer­i­can Di­etet­ic As­so­ci­a­tion: in­di­vid­u­al­ized nu­tri­tion ap­proach­es for older adults in health care com­mu­ni­ties. J Am Diet Assoc 2010;110:1554–1563
49. Migdal A, Yaran­di SS, Smi­ley D, Umpier­rez GE. Up­date on di­a­betes in the el­der­ly and in nurs­ing home res­i­dents. J Am Med Dir Assoc 2011;12:627–632.e2
50. Pasquel FJ, Pow­ell W, Peng L, et al. A ran­dom­ized con­trolled trial com­par­ing treat­ment with oral agents and basal in­sulin in el­der­ly pa­tients with type 2 di­a­betes in long-‍term care fa­cil­i­ties. BMJ Open Di­a­betes Res Care 2015; 3:e000104
51. Quinn K, Hud­son P, Dun­ning T. Di­a­betes man­age­ment in pa­tients re­ceiv­ing pal­lia­tive care. J Pain Symp­tom Man­age 2006;32:275–286
52. Ford-‍Dunn S, Smith A, Quin J. Man­age­ment of di­a­betes dur­ing the last days of life: at­ti­tudes of con­sul­tant di­a­betol­o­gists and con­sul­tant pal­lia­tive care physi­cians in the UK. Pal­li­at Med 2006;20:197–203
53. Mallery LH, Ran­som T, Steeves B, Cook B, Dun­bar P, Moor­house P. Ev­i­dence-‍in­formed guide­lines for treat­ing frail older adults with type 2 di­a­betes: from the Di­a­betes Care Pro­gram of Nova Sco­tia (DCPNS) and the Pal­li­ative and Ther­a­peu­tic Har­mo­niza­tion (PATH) pro­gram. J Am Med Dir Assoc 2013;14:801–808
54. Laiteer­apong N, Ive­niuk J, John PM, Lau­mann EO, Huang ES. Clas­sification of older adults who have di­a­betes by co­mor­bid con­di­tions, Unit­ed States, 2005-2006. Prev Chron­ic Dis 2012;9:E100
55. Mun­shi MN, Slyne C, Segal AR, Saul N, Lyons C, Weinger K. Lib­er­at­ing A1C goals in older adults may not pro­tect against the risk of hy­p­ogycemia. J Di­a­betes Com­pli­ca­tions 2017;31:1197–1199
56. Leung E, Won­grak­panich S, Mun­shi MN. Di­a­betes man­age­ment in the el­der­ly. Di­a­betes Spec­tr 2018;31:245–253